KEYS POINTS

• A longitudinal observational study was conducted on 14 patients (7 in the intervention group, 7 in the control group), with data collected at baseline and at 6 weeks.

• There is no statistically significant differences were observed between groups in HIT-6 score (headache-related quality of life) Pain and disability (VAS) and Self-efficacy score (PSEQ)

• 57% of physiotherapy patients reported a perceived reduction in medication use, compared to 14% in the control group. Most common techniques included muscle strengthening and aerobic exercise.

• Although the results did not reach statistical significance, they suggest a potential benefit of physiotherapy in helping reduce medication use among patients with CDH. In clinical practice, physiotherapy could represent a complementary therapeutic option, focused on reducing disability and supporting withdrawal from acute medication use.

BIBLIOGRAPHIE

1. Principaux repères sur les céphalées [Internet]. [cité 17 avr 2025]. Disponible sur: https://www.who.int/fr/news-room/fact-sheets/detail/headache-disorders
2. Gilles Géraud, Nelly Fabre, Michel Lantéri-Minet, Dominique Valade. Les céphalées en 30leçons. 2e éd.
3. Démarche diagnostique généraledevant une céphalée chronique  quotidienne (CCQ) – Prise en charge d’une  CCQ chez le migraineux : céphalée par abus  médicamenteux et migraine chronique.pdf [Internet]. [cité 17 avr 2025]. Disponible sur: https://www.sfetd-douleur.org/wp-content/uploads/2019/06/cahier_sfetd_n_3_ccq.pdf
4. The Global Burden of Headache – PubMed [Internet]. [cité 17 avr 2025]. Disponible sur: https://pubmed.ncbi.nlm.nih.gov/29791944/
5. O’Hayon Naïm R, Escher M. Antalgiques en automédication : quels sont les risques ? Rev Med Suisse. 30 juin 2010;255(25):1338‑41.
6. Munksgaard SB, Madsen SK, Wienecke T. Treatment of medication overuse headache-A review. Acta Neurol Scand. mai 2019;139(5):405‑14.
7. Diener HC, Dodick D, Evers S, Holle D, Jensen RH, Lipton RB, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. sept 2019;18(9):891‑902.
8. Anthony Demont. Impacts de l’activité physique chez les patients souffrant de céphalées ou de migraine [Internet]. [cité 17 avr 2025]. Disponible sur: https://www.edimark.fr/revues/la-lettre-du-neurologue/vol-xxviii-n-6/impacts-de-lactivite-physique-chez-les-patients-souffrant-decephalees-ou-de-migraine
9. Chaibi A, Russell MB. Manual therapies for primary chronic headaches: a systematic review of randomized controlled trials. J Headache Pain. 2 oct 2014;15(1):67.
10. Muñoz-Gómez E, Serra-Añó P, Mollà-Casanova S, Sempere-Rubio N, Aguilar-Rodríguez M, Espí-López GV, et al. Potential Add-On Effects of Manual Therapy Techniques in Migraine Patients: A Randomised Controlled Trial. J Clin Med. janv 2022;11(16):4686.
11. Fernando Prieto Peres M, Prieto Peres Mercante J, Belitardo de Oliveira A. Non-Pharmacological Treatment for Primary Headaches Prevention and Lifestyle Changes in a Low-Income Community of Brazil: A Randomized Clinical Trial. Headache. janv 2019;59(1):86‑96.
12. Wells RE, O’Connell N, Pierce CR, Estave P, Penzien DB, Loder E, et al. Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine: A Randomized Clinical Trial. JAMA Intern Med. 1 mars 2021;181(3):317‑28.
13. Grazzi L, Andrasik F, Rizzoli P, Bernstein C, Sansone E, Raggi A. Acceptance and commitment therapy for high frequency episodic migraine without aura: Findings from a randomized pilot investigation. Headache. juin 2021;61(6):895‑905.
14. Benatto MT, Florencio LL, Bragatto MM, Dach F, Fernández-de-las-Peñas C, Bevilaqua-Grossi D. Neck-specific strengthening exercise compared with placebo sham ultrasound in patients with migraine: a randomized controlled trial. BMC Neurol. déc 2022;22(1):126.
15. Rinne M, Garam S, Häkkinen A, Ylinen J, Kukkonen-Harjula K, Nikander R. Therapeutic Exercise Training to Reduce Chronic Headache in Working Women: Design of a Randomized Controlled Trial. Phys Ther. mai 2016;96(5):631‑40.
16. Rinne M, Garam S, Kukkonen-Harjula K, Tokola K, Häkkinen A, Ylinen J, et al. Neck-Shoulder Region Training for Chronic Headache in Women: A Randomized Controlled Trial. Clin Rehabil. oct 2023;37(10):1322‑31.
17. Martín-Vera D, Sánchez-Sierra A, González-de-la-Flor Á, García-Pérez-de-Sevilla G, Domínguez-Balmaseda D, Del-Blanco-Muñiz JÁ. Efficacy of a strength-based exercise program in patients with chronic tension type headache: a randomized controlled trial. Front Neurol. 2023;14:1256303.
18. Aguirrezabal I, Pérez de San Román MS, Cobos-Campos R, Orruño E, Goicoechea A, Martínez de la Eranueva R, et al. Effectiveness of a primary care-based group educational intervention in the management of patients with migraine: a randomized controlled trial. Prim Health Care Res Dev. 13 déc 2019;20:e155.
19. Meise R, Carvalho GF, Thiel C, Luedtke K. Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine: A randomized controlled trial. Cephalalgia Int J Headache. févr 2023;43(2):3331024221144781.
20. Ashina S, Ashina M. Current and potential future drug therapies for tension-type headache. Curr Pain Headache Rep. déc 2003;7(6):466‑74.
21. Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. févr 2018;17(2):174‑82.
22. Gedda M. Traduction française des lignes directrices STROBE pour l’écriture et la lecture des études observationnelles. Kinésithérapie Rev. 1 janv 2015;15(157):34‑8.
23. Dubé MO, Langevin P, Roy JS. Measurement properties of the Pain Self-Efficacy Questionnaire in populations with musculoskeletal disorders: a systematic review. PAIN Rep. nov 2021;6(4):e972.
24. Dubé MO, Roos M, Desmeules F, Roy JS. Reliability, validity, and responsiveness of a Canadian French adaptation of the pain self-efficacy questionnaire (PSEQ). Disabil Rehabil. août 2023;45(16):2675‑82.